SCHEMBL6930187

SCHEMBL6930187

CC/C=C/C/C=C/C/C=C/C/C=C/CCCCC(=O)OC

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.71
CYP3A4 P08684 2/20 0.71
ALOX15 P16050 2/20 0.71
HSD17B10 Q99714 2/20 0.71
TDP1 Q9NUW8 2/20 0.71
TSHR P16473 1/20 0.71
NR1I2 O75469 2/20 0.65
PTGS2 P35354 2/20 0.65
ADORA3 P0DMS8 2/20 0.65
PGR P06401 1/20 0.65
PDE4D Q08499 1/20 0.65
OXER1 Q8TDS5 4/20 0.64
F7 P08709 3/20 0.64
F3 P13726 3/20 0.64
CYP19A1 P11511 3/20 0.64
MAPT P10636 2/20 0.64
PTGS1 P23219 2/20 0.64
PPARG P37231 2/20 0.64
KMT2A Q03164 2/20 0.64
PPARD Q03181 2/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6930194 1.00 ALDH1A1 (0.71) ALDH1A1CYP3A4ALOX15HSD17B10TDP1
SCHEMBL16002390 1.00 ALDH1A1 (0.71) ALDH1A1CYP3A4ALOX15HSD17B10TDP1
SCHEMBL14242243 1.00 ALDH1A1 (0.71) ALDH1A1CYP3A4ALOX15HSD17B10TDP1
SCHEMBL7712920 1.00 ALDH1A1 (0.71) ALDH1A1CYP3A4ALOX15HSD17B10TDP1
SCHEMBL16002433 1.00 ALDH1A1 (0.71) ALDH1A1CYP3A4ALOX15HSD17B10TDP1
SCHEMBL25216159 0.98 ALDH1A1 (0.73) ALDH1A1CYP3A4ALOX15HSD17B10TDP1
Methyl Linolenate SCHEMBL23291762 0.98 ALDH1A1 (0.73) ALDH1A1CYP3A4ALOX15HSD17B10TDP1
SCHEMBL23067666 0.98 ALDH1A1 (0.73) ALDH1A1CYP3A4ALOX15HSD17B10TDP1
SCHEMBL16002473 0.98 ALDH1A1 (0.73) ALDH1A1CYP3A4ALOX15HSD17B10TDP1
SCHEMBL23067665 0.98 ALDH1A1 (0.73) ALDH1A1CYP3A4ALOX15HSD17B10TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0904072-A4 METHODS OF TREATING IMMUNOPATHOLOGIES USING POLYUNSATURATED FATTYACIDS PEPTIDE TECHNOLOGY PTY LTD (AU) 2003-07-30 EP disclosed
US-6376688-B1 Modified polyunsaturated fatty acids PEPTIDE TECHNOLOGY LIMITED (AU) 2002-04-23 US disclosed
US-6262119-B1 ADMINISTERING POLYUNSATURATED FATTY ACID CONTAINING 18-25 CARBONS, 1-6 DOUBLE BONDS AND HAS ONE OR TWO SUBSTITUTIONS FOR THERAPY OF T-CELL MEDIATED DISEASES SUCH AS DIABETES, MULTIPLE SCLEROSIS, RHEUMATOID ARTHRITIS, HERPES SIMPLEX ETC. PEPTIDE TECHNOLOGY LIMITED (AU) 2001-07-17 US disclosed
EP-0904072-A1 METHODS OF TREATING IMMUNOPATHOLOGIES USING POLYUNSATURATED FATTYACIDS Peptide Technology Pty. Ltd. (AU) 1999-03-31 EP disclosed
WO-1997038688-A1 METHODS OF TREATING IMMUNOPATHOLOGIES USING POLYUNSATURATED FATTYACIDS PEPTIDE TECHNOLOGY PTY. LIMITED (AU) 1997-10-23 WO disclosed